1<!DOCTYPE html>
2
3Anonymous
4/bestp
5/bestp/domrep.nsf
6D8AA03B53D4E2B8685256B2900734A86
8
9
10
11
12
13
140
15
16
17/bestp/domrep.nsf/products/use-of-imaging-technology-to-support-pharmaceutical-medicines?opendocument
18
19opendocument
2035.172.136.29
21
22
23
24/bestp/domrep.nsf
25DB




Products & Services Business Operations Alliances and Partnerships

Use of Imaging Technology to Support Pharmaceutical Medicines

DB Image

ID: 4245


Features:

Graphics


Words: 3,442


Published: Pre-2016


Delivery Format: Online PDF Document


 

License Options:


Buy Now

 

919-403-0251

  • STUDY OVERVIEW
  • BENCHMARK CLASS
  • SPECIAL OFFER
This research study conducted by Best Practices LLC explores potential relationships between imaging technology companies and pharmaceutical companies. The trend towards Total Patient Management Systems has the possibility of leading to alliances between diagnostic/imaging companies and pharmaceutical companies. Potential partnerships provide strategic opportunities to leverage imaging technology to increase the demand for drug treatments — improving patient outcomes

Industries Profiled:
Pharmaceutical; Manufacturing; Biotech; Consumer Products; Diagnostic; Medical Device; Health Care; Telecommunications; Professional Services; Energy


Companies Profiled:
Bayer; DuPont Pharmaceuticals; GlaxoSmithKline; Hitachi Medical Systems; Hologic; Berlex Laboratories; ADAC Labs; Amersham; Merck; Siemens

If you purchase Best Practice Database document(s), you will have 30 days from the date of purchase to apply some or all of the cost of the document(s) toward the cost of a Full Access Individual, Pharma, Group or University Membership. Write us at DatabaseTeam@bestpracticesllc.com or call David Guinn at 919-767-9179 if you have any questions.